Thyroid Panel Interpretation
Your thyroid panel shows elevated FT4 (2.36 ng/dL) with normal TSH (1.48 mIU/L), which most likely represents laboratory assay interference rather than true thyroid dysfunction, and requires confirmation with a different testing platform before any treatment decisions.
Initial Assessment
The pattern you present—elevated FT4 with normal TSH and normal-to-borderline FT3—is biochemically inconsistent with typical thyroid disorders. In true hyperthyroidism, TSH would be suppressed (typically <0.1 mIU/L) 1. Your TSH of 1.48 mIU/L falls well within the normal reference range, creating a discordant picture.
Most Likely Explanation: Assay Interference
This pattern strongly suggests laboratory assay interference rather than genuine thyroid disease 2. Key evidence:
Immunoassay interference is well-documented with thyroid hormone measurements, particularly in patients with:
- High titers of anti-thyroid antibodies (anti-TPO, anti-Tg)
- Heterophile antibodies
- Rheumatoid factor
- Other interfering substances 2
A documented case showed FT4 of 4.59 ng/dL on Roche platform but only 1.08 ng/dL (normal) on Abbott platform in the same patient, confirming platform-specific interference 2
Recommended Diagnostic Approach
Immediate next steps:
Retest on a different immunoassay platform (e.g., if initially tested on Roche/Siemens, retest on Abbott or vice versa) 2
- This is the definitive way to identify assay interference
- Results should be obtained within 1-2 weeks
Assess for clinical signs of hyperthyroidism:
- Tachycardia, palpitations, atrial fibrillation
- Weight loss despite normal appetite
- Heat intolerance, excessive sweating
- Tremor, anxiety, hyperreflexia
- If these are absent, true hyperthyroidism is highly unlikely 1
Check for interfering antibodies:
- Anti-TPO and anti-thyroglobulin antibodies
- These are common causes of FT4/FT3 measurement interference 2
Alternative (Less Likely) Considerations
Syndrome of Inappropriate TSH Secretion (SITSH)
- Characterized by elevated FT4 with normal/elevated TSH 3
- However, your TSH is mid-normal (not elevated), making this unlikely
- SITSH is associated with TSH-secreting pituitary adenomas or thyroid hormone resistance—both rare
Central Hypothyroidism
- Would show low FT4 with inappropriately normal TSH 4
- Your elevated FT4 excludes this diagnosis
Medication/Supplement Effects
- Recent levothyroxine ingestion (even if not prescribed to you)
- Biotin supplementation can cause falsely elevated FT4 on certain platforms
- Amiodarone or iodinated contrast exposure 4
Critical Pitfalls to Avoid
Do not initiate antithyroid treatment based on these results alone 1
- The normal TSH with elevated FT4 pattern is not consistent with endogenous hyperthyroidism requiring treatment
- Antithyroid drugs carry risks including agranulocytosis 1
Do not assume euthyroidism without confirmation
- While assay interference is most likely, rare conditions exist
- Confirmation testing is mandatory
Do not order radioactive iodine uptake scan yet 1
- This is indicated when TSH is <0.45 mIU/L with elevated thyroid hormones
- Your normal TSH makes this premature
Clinical Context Matters
If you are clinically euthyroid (no symptoms of hyper- or hypothyroidism), this strongly supports assay interference as the explanation 2, 5.
If you have symptoms, the discordant labs still require platform verification before attributing symptoms to thyroid dysfunction.
Follow-Up Timeline
- Retest within 2 weeks if you have cardiac symptoms (palpitations, atrial fibrillation) 1
- Retest within 4 weeks if asymptomatic 1
- Use a different laboratory platform for confirmation 2
The FT3 value of 2.19 pg/mL appears within typical reference ranges (generally 1.5-4.4 pg/mL depending on assay) 6, 7, which further supports that true hyperthyroidism is not present, as FT3 is typically the most sensitive marker for hyperthyroidism 8, 9.